KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Total Current Liabilities (2016 - 2025)

Biogen (BIIB) has 17 years of Total Current Liabilities data on record, last reported at $3.3 billion in Q4 2025.

  • For Q4 2025, Total Current Liabilities fell 39.42% year-over-year to $3.3 billion; the TTM value through Dec 2025 reached $3.3 billion, down 39.42%, while the annual FY2025 figure was $3.3 billion, 39.42% down from the prior year.
  • Total Current Liabilities reached $3.3 billion in Q4 2025 per BIIB's latest filing, up from $3.2 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $5.5 billion in Q4 2024 and bottomed at $3.0 billion in Q1 2023.
  • Average Total Current Liabilities over 5 years is $3.9 billion, with a median of $3.4 billion recorded in 2023.
  • Peak YoY movement for Total Current Liabilities: surged 60.99% in 2024, then crashed 39.42% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $4.3 billion in 2021, then decreased by 23.86% to $3.3 billion in 2022, then increased by 4.93% to $3.4 billion in 2023, then skyrocketed by 60.99% to $5.5 billion in 2024, then plummeted by 39.42% to $3.3 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $3.3 billion in Q4 2025, $3.2 billion in Q2 2025, and $5.5 billion in Q4 2024.